SCHEMBL15060527

SCHEMBL15060527

CC(=O)CC(=O)CC(=O)CC(=O)C(=O)CCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHF8 Q9UPP1 7/20 0.64
▸ KDM2A Q9Y2K7 7/20 0.64
▸ EGLN1 Q9GZT9 5/20 0.64
▸ KDM4E B2RXH2 4/20 0.64
▸ KDM5C P41229 4/20 0.64
▸ KDM6B O15054 2/20 0.64
▸ LMNA P02545 3/20 0.48
▸ SLC15A2 Q16348 1/20 0.48
▸ MAPK1 P28482 1/20 0.42
▸ SLC13A3 Q8WWT9 1/20 0.42
▸ OR51E2 Q9H255 1/20 0.42
▸ GABRR1 P24046 1/20 0.39
▸ ALKBH5 Q6P6C2 1/20 0.39
▸ SUCNR1 Q9BXA5 1/20 0.39
▸ FOLH1 Q04609 1/20 0.34
▸ KDM7A Q6ZMT4 1/20 0.34
▸ FFAR3 O14843 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9839290 0.84 PHF8 (0.90) PHF8KDM2AEGLN1KDM4EKDM5C
Succinylacetone SCHEMBL503918 0.79 PHF8 (1.00) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL27867093 0.77 EGLN1 (0.48) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL1774230 0.76 EGLN1 (0.59) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL28977856 0.76 EGLN1 (0.59) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL10936077 0.75 KDM4E (0.55) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL26967576 0.75 KDM4E (0.55) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL3221131 0.74 EGLN1 (0.50) PHF8KDM2AEGLN1KDM4EKDM5C
SCHEMBL28887 0.73 EGLN1 (0.62) PHF8KDM2AEGLN1KDM4EKDM5C
Succinic Acid SCHEMBL8382879 0.73 PHF8 (0.70) PHF8KDM2AEGLN1KDM4EKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470874-B2 Pharmaceutical compositions comprising cannabichromene type compounds GW PHARMA LIMITED (GB) 2013-06-25 — — US disclosed
US-8470874-B2 Pharmaceutical compositions comprising cannabichromene type compounds GW PHARMA LIMITED (GB) 2013-06-25 — — US disclosed
Send feedback